Skip to content
healthcare.dev

GABAPENTIN

NDC 72737-005, GABAPENTIN, capsule, from STALLION LABORATORIES PRIVATE LIMITED.

Product NDC
72737-005
Status
Listed
Labeler
STALLION LABORATORIES PRIVATE LIMITED
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219319
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72737-005 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GABAPENTIN100 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
72737-005-017273700050130 CAPSULE in 1 BOTTLE (72737-005-01)
72737-005-0272737000502100 CAPSULE in 1 BOTTLE (72737-005-02)
72737-005-0372737000503500 CAPSULE in 1 BOTTLE (72737-005-03)
72737-005-04727370005041000 CAPSULE in 1 BOTTLE (72737-005-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b26fd0c6-6aab-4957-8a32-cc7adb9b5fc9

Use it

Look up 72737-005 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72737-005 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72737-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.